--- a
+++ b/clusters/3009knumclusters/clust_195.txt
@@ -0,0 +1,520 @@
+STEP I: The following patients will be excluded:\r\n* Pregnant women\r\n* Nursing women
+STEP II: The following patients will be excluded:\r\n* Pregnant women\r\n* Nursing women
+No patients that are known to be pregnant or nursing
+Not pregnant and not nursing
+Pregnancy and/or nursing females
+Nursing mothers are excluded
+Women who are pregnant or nursing
+Subject is pregnant, nursing or intends to become pregnant during the course of the study.
+Pregnant or nursing female patients.
+Female patients who are pregnant or nursing
+Pregnant and nursing women are excluded from this study
+Pregnant and nursing females.
+Pregnant or nursing women
+Pregnant or nursing women
+Female patients who are pregnant or nursing are not eligible
+Pregnant and nursing mothers are excluded from this study.
+Pregnant or nursing women
+Pregnant or nursing (lactating) women.
+Any of the following:\r\n* Pregnant women\r\n* Nursing women
+Females who are pregnant or nursing
+Patients who are pregnant or actively nursing an infant are not eligible
+Nursing women
+Pregnant or nursing (lactating) women
+Pregnant or nursing
+Pregnant or nursing mothers are excluded
+Pregnant/nursing
+Pregnant, or nursing female patient Previous treatment
+Pregnant or nursing.
+Pregnant or nursing women.
+Are pregnant and/or nursing
+Pregnant or nursing women will be excluded from the study
+Women who are pregnant or nursing a child may not take part in this study
+Pregnant or nursing females
+Women who are pregnant or nursing
+Pregnant or nursing women will be excluded from the study
+Pregnant women are excluded from this study; nursing mothers should stop breastfeeding to be eligible
+For female subjects of childbearing potential: Is pregnant or nursing
+Female patients who are pregnant or nursing are not eligible
+Pregnant or nursing
+Pregnant or nursing
+Pregnant and nursing subjects are excluded
+Nursing women
+Pregnant/nursing female
+Pregnant or nursing
+Pregnant or nursing women are excluded
+Patients who are pregnant or nursing
+Pregnant or nursing females.
+Pregnant or nursing female patients
+Pregnant or nursing women
+Pregnant or nursing women
+Nursing women
+Pregnant or nursing female subjects
+Pregnant or nursing women
+Female subjects who are pregnant, intend to become pregnant or are nursing
+Pregnant or nursing women
+Pregnant or nursing female participants
+Patients who are pregnant or nursing.
+Pregnant and nursing women
+Pregnant or nursing women
+Pregnant or nursing women
+Women who are pregnant or nursing are not eligible as treatment involves unforeseeable risks to the fetus or child
+Nursing or pregnant women
+Patient is pregnant or nursing
+Nursing or pregnant women
+Pregnant or nursing female subjects
+Pregnant or nursing female participants
+Women who are pregnant or nursing.
+Pregnant or nursing
+Patients must not be pregnant or nursing
+Pregnant or nursing female participants
+Females who are pregnant or nursing
+Pregnant or nursing women
+Female patients who are pregnant or nursing are not eligible
+Women who are pregnant or nursing or plan to become pregnant or nurse during the course of the study
+Female patients will not be eligible for this study if she is either pregnant or nursing at the time of enrollment
+Female patients who are pregnant or nursing.
+Subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants.
+Pregnant and nursing women are excluded because of the potential teratogenic effects and potential unknown effects on nursing newborns (please see above paragraph under inclusion criteria regarding WOCBP)
+Pregnant or nursing women
+Pregnant and nursing women are excluded from this study
+Female patients who are pregnant or nursing are not eligible
+Pregnant or nursing women
+Subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants
+Women who are pregnant or nursing.
+Nursing or pregnant women
+Any of the following:\r\n* Pregnant women\r\n* Nursing women
+May not be pregnant or nursing
+Be female and pregnant or nursing.
+Pregnant or nursing women
+Pregnant or nursing (lactating) women; breastfeeding should be discontinued
+Pregnant or nursing women
+Women who are pregnant, nursing, or who plan to become pregnant while in the trial
+Pregnant or nursing female participants
+Pregnant or nursing female participants
+Non-pregnant and non-nursing; pregnant and nursing patients may not be enrolled; women and men of reproductive potential must agree to use acceptable forms of contraception during the study
+Pregnant or nursing
+Female patients who are pregnant or nursing are not eligible
+Patients who are pregnant or nursing
+Pregnant or nursing women
+Nursing women
+Pregnant and nursing women are excluded from this study
+Pregnant or nursing
+Female patients who are pregnant or nursing are not eligible
+Pregnant or nursing women
+Pregnant or nursing women
+Subjects who are pregnant or nursing
+Pregnant or nursing women are excluded from this study
+Patients who are pregnant or nursing
+Female subjects who are pregnant, intend to become pregnant or are nursing
+Pregnant or nursing
+Subjects must not be pregnant or nursing
+Pregnant or nursing patients
+Pregnant and nursing women are excluded
+Pregnant or nursing
+Patients who are pregnant or nursing are excluded
+Pregnant or nursing (lactating) women
+Pregnant or nursing
+PHASE I: Patients must not be pregnant or nursing as the potential of this regimen to harm nursing infants has not been evaluated
+PHASE II: Patients must not be pregnant or nursing as the potential of this regimen to harm nursing infants has not been evaluated
+Subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants.
+Female patients who are pregnant or nursing are not eligible
+Pregnant or nursing women
+Pregnant or nursing (lactating) women
+Nursing women
+Patients who are pregnant or nursing
+Pregnant or nursing women
+Patients who are pregnant or nursing
+Pregnant or nursing women.
+Pregnant or nursing women
+Pregnant or nursing patients
+Pregnant women or nursing mothers
+Pregnant and nursing mothers are excluded from this study
+Female patients who are either pregnant or nursing.
+Pregnant or nursing women
+Pregnant or nursing women
+Pregnant or nursing women
+Nursing women may participate only if nursing is discontinued
+Women who are pregnant or nursing
+Subjects must not be pregnant or nursing
+Pregnant or nursing women
+Pregnant or nursing
+Study drug must not be administered to pregnant women or nursing mothers
+Patients who are pregnant or nursing
+Subjects must not be pregnant or nursing
+Pregnant or nursing (lactating) women
+Pregnant women or nursing mothers
+Not pregnant and not nursing
+Pregnant or nursing (lactating) women
+Women who are pregnant or nursing
+Patients who are pregnant or nursing (Turnstile I)
+Women who are pregnant or nursing.
+Subjects who are pregnant or nursing
+Pregnant or nursing female subjects
+Pregnant women or nursing mothers
+Women who are pregnant or nursing
+Subjects must not be pregnant or nursing
+Females who are pregnant, intend to become pregnant, or are nursing at the time of randomization.
+Pregnant or nursing female patients
+Patients who are pregnant or nursing (Turnstile I)
+Pregnant women or nursing mothers
+Patients who are pregnant or nursing
+Are pregnant and/or nursing
+Pregnant or nursing women are excluded from this study
+EXCLUSION CRITERIA FOR REGISTRATION: pregnant or nursing women are excluded from this study
+Patient must not be pregnant because of the risk of harm to the fetus; nursing women may participate only if nursing is discontinued, due to the possibility of harm to nursing infants from the treatment regimen; women/men of reproductive potential must agree to use an effective contraception method
+Pregnant or nursing (lactating) women
+Pregnant or nursing women
+Pregnancy or nursing patients will be excluded from the study
+Pregnant or nursing women
+Pregnancy or nursing
+Not pregnant or nursing
+Pregnant and nursing women.
+Pregnant or nursing female participants
+Pregnancy or nursing
+Women who are pregnant or nursing
+Female subjects who are pregnant or nursing
+Women who are pregnant or nursing
+Pregnant or nursing at the time of signing informed consent
+Lactating females must agree to discontinue nursing
+Pregnant or nursing women
+Pregnant or nursing females.
+Nursing or pregnant females or females who plan pregnancy during the duration of the study.
+Pregnant or nursing women.
+Nursing women
+Are not pregnant or nursing;
+Patients must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants
+Pregnant or nursing
+Pregnant or nursing
+Female patients who are pregnant or nursing are not eligible
+Patients must not be nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants
+Patients must not be pregnant or nursing
+May not be pregnant or nursing
+Patients must not be pregnant or nursing
+Subjects known to be pregnant or nursing.
+Pregnant or nursing
+Pregnant or nursing females
+Nursing women who are unwilling to discontinue nursing
+Female patients who are pregnant or nursing are not eligible
+Pregnant or nursing female patients are excluded from this study
+ARM A: Pregnant or nursing women
+ARM B: Pregnant or nursing women
+DOSE ESCALATION COHORT: Pregnant or nursing
+DOSE EXPANSION COHORT: Pregnant or nursing
+Any of the following:\r\n* Pregnant women\r\n* Nursing women
+Pregnant or nursing women
+Pregnant or nursing women
+Pregnant women are excluded from this study; nursing women are excluded from this study
+Nursing woman
+Pregnant women are excluded from this study; nursing women are excluded from this study
+Any of the following:\r\n* Pregnant women\r\n* Nursing women
+Pregnant or nursing.
+Women who are pregnant or nursing
+Pregnant or nursing women
+Pregnant or nursing
+Pregnant or nursing mothers
+Pregnant or nursing women
+Women who are pregnant or are nursing
+Pregnant or nursing female patients
+Women who are pregnant or nursing
+Patients who are pregnant or nursing are excluded
+Pregnancy or nursing Mother
+Patients who are pregnant or nursing are excluded
+Pregnant/nursing women are excluded from this study because oxaliplatin is an agent with the potential for teratogenic or abortifacient effects
+Pregnant and nursing women are excluded from this study
+Not pregnant or nursing
+Pregnant women or nursing mothers
+Pregnant or nursing
+Pregnant or nursing
+Patients who are pregnant or nursing
+Patients of childbearing potential, not practicing adequate contraception, patients who are pregnant or patients who are nursing are not eligible for this trial; bevacizumab should not be administered to nursing women
+Pregnant and nursing females.
+Patients who are pregnant or nursing
+Is a female who is pregnant, nursing, or breastfeeding, or who intends to become pregnant during the participation in the study
+Pregnant or nursing (lactating) women
+Pregnant, planning to become pregnant, or nursing
+Pregnant or nursing (lactating) women
+Pregnant or nursing women
+Non-pregnant and non-nursing
+Pregnant or nursing
+Females who are pregnant, nursing or breastfeeding, or intend to become pregnant during the participation to the study
+Pregnant or nursing women.
+Pregnant, planning to become pregnant, or nursing
+Pregnant or nursing women
+Is pregnant or nursing
+Women who are pregnant, nursing, or who plan to become pregnant while in the trial
+Is a female who is pregnant, nursing, or breastfeeding, or who intends to become pregnant during the participation in the study
+Pregnant or nursing
+Pregnant or nursing female participants
+Women who are pregnant or nursing.
+No women who are pregnant or nursing
+Currently pregnant, nursing, or wishing to become pregnant during the study
+Pregnant or nursing female participants
+Pregnant women or nursing women
+Women who are pregnant or nursing (lactating).
+Patients must be non-pregnant and non-nursing
+Pregnant women and/or nursing patients will be excluded from the study
+Females who are nursing must agree to discontinue nursing before the first dose of GS-5829
+Pregnant or nursing; or
+Women who are pregnant or nursing
+Patient is pregnant or nursing or physiologically capable of becoming pregnant and not using highly effective contraception
+Patients who are pregnant or nursing
+Nursing and pregnant females
+Pregnant or nursing (lactating) women.
+Pregnancy or nursing
+Pregnant or nursing
+Females who are nursing must agree to discontinue nursing before the first dose of study drug
+Women who are pregnant or nursing/breastfeeding
+Pregnant or nursing women
+Pregnant or nursing females.
+Women who are pregnant or nursing (lactating) women
+Female patients who are pregnant or nursing (lactating) are not eligible
+Pregnant or nursing women will be excluded from the study
+Female patients who are pregnant or nursing are not eligible
+Female patients who are pregnant or nursing are not eligible
+Participants who are pregnant or nursing
+Subjects must not be pregnant or nursing
+Pregnant or nursing
+Women that are pregnant or nursing
+Pregnant or nursing.
+Pregnant and nursing women
+Pregnant or nursing patients will be excluded from the study
+Any of the following\r\n* Pregnant women\r\n* Nursing women
+Pregnant or nursing women will be excluded from the study
+Patients who are pregnant or nursing
+Pregnant women and nursing mothers
+Pregnant or nursing (lactating) women
+Pregnant or nursing women
+Pregnant or nursing females
+Pregnant and nursing women are excluded from this study
+Pregnant or nursing (lactating) women
+Patients who are pregnant or nursing
+Females who are nursing must agree to discontinue nursing before the first dose of MMB
+Pregnant or nursing female subjects
+Patients who are pregnant or nursing are not eligible
+Pregnant or nursing
+Nursing women
+Pregnant and nursing women are excluded from this study
+Women who are pregnant or nursing/breastfeeding.
+Pregnant or nursing (lactating) women
+Pregnant or nursing (lactating) women
+Pregnant or nursing within past 6 months, or plans to become pregnant in the next year
+Pregnant or nursing (lactating) women
+Pregnant or nursing women
+Pregnant women and nursing women are excluded from this study
+Patient must not be pregnant or nursing
+Are pregnant or nursing, or intending to become pregnant within the duration of the study
+Pregnant or nursing
+Pregnant or nursing
+Patients pregnant or nursing
+Pregnant or nursing (lactating) women.
+Pregnant or nursing women
+Pregnant or nursing within past 6 months
+Non-pregnant and non-nursing; pregnant or nursing patients may not be enrolled; women and men of reproductive potential should agree to use an effective means of birth control
+Pregnant or nursing women
+Patients who are pregnant or nursing
+Pregnant or nursing (lactating) women.
+Nursing female.
+Pregnant or nursing women
+Pregnant or nursing females
+Nursing women
+Pregnant women and nursing patients will be excluded
+Patient is pregnant or nursing
+not pregnant or nursing; Female participants must not breastfeed during the study and for a period of 30 days following the last dose.
+Pregnant or nursing
+Patients who are pregnant or nursing.
+Nursing women
+Not pregnant or nursing
+Nursing women.
+Pregnant or nursing women
+Pregnancy and/or nursing mothers
+Pregnant or nursing (lactating) women
+Subject is nursing or intends to begin nursing during the course of the study
+Pregnant or nursing
+Pregnant or nursing (lactating) women
+Pregnancy or nursing
+Pregnant or nursing female patients
+Nursing or pregnant.
+Pregnant or nursing women may not participate in this trial
+Pregnant or nursing female subjects
+Pregnant and nursing patients will be excluded from the study
+Pregnant or nursing patients will be excluded from the study
+Pregnant, nursing or planning to become pregnant
+Pregnant or nursing women.
+Patients who are pregnant, nursing, or who wish to become pregnant during the study
+Nursing women
+Patients who are pregnant or nursing
+Is, within 2 weeks prior to Day 1, nursing.
+Pregnant and nursing women are excluded from this study
+Females who are pregnant or nursing.
+Pregnant or nursing female patients.
+Pregnant or nursing women
+Pregnant or nursing female patients
+Pregnant or nursing women
+Pregnant or nursing
+Is nursing or pregnant
+Females who are pregnant or currently nursing.
+Pregnant or nursing women.
+Pregnant or nursing women
+Pregnant or nursing (lactating) women
+Pregnant or nursing females
+Women who are pregnant and/or nursing
+Pregnant women or nursing women
+Currently pregnant or nursing.
+Is nursing or pregnant
+Pregnant or nursing females;
+patient was pregnant or nursing at the time of entry
+Pregnant or nursing women; breastfeeding must be discontinued prior to treatment
+Pregnant or nursing females.
+Females who are nursing.
+Pregnant or nursing
+Patients must not be pregnant or nursing
+Pregnant or nursing female patients
+Patients must not be pregnant or nursing
+Participant is nursing or intends to begin nursing during the course of the study
+Subject is pregnant or nursing an infant
+Are pregnant or nursing
+Pregnant or nursing women
+Pregnant or nursing
+Pregnant or nursing females.
+Women who are pregnant or nursing.
+Pregnant or nursing women
+Pregnant or nursing mothers
+Pregnant or nursing women. Pregnant and nursing patients are excluded because the effects of CWP232291 on a fetus or nursing child are unknown.
+Pregnant or nursing
+Participants who are pregnant or nursing
+Pregnant or nursing women Part 3 Exclusion Criteria:
+Pregnant or nursing women Part 4 Exclusion Criteria:
+Pregnant or nursing women
+Pregnant or nursing women
+Female subjects cannot be pregnant or nursing.
+Pregnant or nursing
+Pregnant or nursing women will be excluded from study.
+Not pregnant or nursing
+Pregnant or nursing women are excluded
+Women who are pregnant or nursing (pregnancy test to be performed within 24 hours prior to HIFU treatment)
+Pregnant and nursing women
+Female patients who are pregnant or nursing are not eligible
+Pregnant or nursing female patients
+Patients who are pregnant or nursing
+Women who are pregnant or nursing (pregnancy test to be performed within 24 hours prior to HIFU treatment)
+Patients who are pregnant or nursing are ineligible
+Pregnant or nursing female patients
+Pregnant or nursing female patients
+Females who are nursing
+Pregnant or nursing
+Pregnant or nursing
+Patient is pregnant or nursing
+Subject is pregnant, nursing, or planning to get pregnant during study duration.
+Female patients who are pregnant or nursing are not eligible.
+Known pregnancy or nursing
+Patient is pregnant or nursing
+Pregnant or nursing women
+Pregnant or nursing female subjects; may be determined in the preoperative evaluation
+Pregnant or nursing female participants
+Pregnant or nursing women
+Participant is pregnant or nursing
+Pregnant or nursing women
+Women who are pregnant, lactating/nursing or plan to become pregnant
+Currently pregnant, nursing or planning to become pregnant
+Pregnant women will be excluded; nursing patients will be included
+Pregnant or nursing women
+Pregnant and nursing women
+Pregnant or nursing female patients
+Women who are known to be pregnant or nursing
+Nursing women
+Pregnant or nursing female patients
+Subject is pregnant or nursing
+Nursing women
+Pregnant or nursing (lactating) women
+Women who are pregnant or nursing; pregnancy will be confirmed by urine test
+Female participants who are pregnant or lactating/nursing
+Women who are nursing
+Women who are nursing
+Not pregnant or nursing
+Pregnant or nursing patients will not be included in the study
+Females of childbearing potential who are pregnant or nursing
+Currently pregnant, nursing, or wishing to become pregnant during the study
+Women who are pregnant, nursing, or who may become pregnant in the next 3 months
+Pregnant women or nursing women
+Women who are pregnant or nursing
+Pregnant or nursing female participants
+Women who are pregnant or nursing, or intend to be/do so during the course of the study
+Women who are pregnant or nursing
+Non-pregnant and non-nursing
+Pregnant or nursing women
+Pregnancy or nursing women
+Nursing women
+Pregnant or nursing women
+Pregnant or nursing (lactating) women
+Nursing or pregnant females
+Subject is pregnant or nursing
+Nursing or pregnant females
+Pregnant or nursing (lactating) women.
+Pregnant or nursing
+Pregnant or nursing
+If a woman is or becomes pregnant or is nursing at any time before or during the treatment period, she will be excluded from the study
+Women who are pregnant or nursing except when the indication is an abnormal cell-free DNA test
+Females who are pregnant or nursing
+Females who are pregnant or nursing
+Women who are pregnant or nursing
+Pregnant or nursing participants
+Pregnant or nursing
+Pregnant or nursing
+Nursing female subjects
+Females who are pregnant or nursing
+Pregnant or nursing (lactating) women
+Patient is pregnant or nursing
+Pregnant or nursing
+Pregnant or nursing
+Pregnant or nursing females
+The patient must not be pregnant or nursing
+Pregnant and/or nursing women
+Patients who are pregnant or nursing
+HEALTHY VOLUNTEER: Females who are pregnant or nursing or are actively lactating
+PATIENT: Females who are pregnant or nursing
+Pregnant or nursing female
+Female patients who are pregnant or nursing
+Female participants/volunteers who are pregnant or nursing
+Female patients who are pregnant or nursing
+Pregnancy or nursing patients
+Pregnant or nursing
+Women who are pregnant or nursing
+Pregnant or nursing females.
+Pregnant or nursing (lactating)
+Pregnant or nursing female
+Pregnant or nursing female
+Pregnant or nursing female
+Pregnant or nursing female
+Pregnant or nursing females
+Pregnant or nursing female
+Pregnant or nursing females
+Pregnant or nursing women
+Patient is pregnant or nursing;
+Females who are pregnant or nursing.
+Patient is pregnant or nursing
+Females who are pregnant or nursing
+Pregnancy or nursing mothers
+Pregnant or nursing patients will be excluded from the study
+Patient is pregnant or nursing
+Pregnant or nursing female subjects
+Women who are pregnant or nursing
+Subjects must not be pregnant or nursing
+Pregnant or nursing female
+Pregnant or nursing
+Are pregnant or nursing
+Females who are pregnant or nursing
+Pregnant or nursing
+Known pregnant or nursing patients
+Subjects who are pregnant or nursing
+Pregnant or nursing patients will be excluded from the study
+Females who are pregnant or nursing
+Pregnant or nursing women
+Pregnant or nursing
+Pregnant and nursing women
+Pregnant or nursing women
+Pregnant or nursing
+Pregnant or nursing
+Pregnant or nursing
+Pregnant or nursing female patients
+Pregnant or nursing patients will be excluded from the study